NK Cells Market

NK Cells Market contains market size and forecasts of NK Cells in global, including the following market information:

• Global NK Cells Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global NK Cells Market Sales, 2017-2022, 2023-2028, (g)
• Global top five NK Cells companies in 2021 (%)

The global NK Cells market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Mogamulizumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of NK Cells include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the NK Cells manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global NK Cells Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (g)

Global NK Cells Market Segment Percentages, by Type, 2021 (%)

• Mogamulizumab
• Lorvotuzumab Mertansine
• Others

Global NK Cells Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (g)

Global NK Cells Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Cardiovascular Diseases
• Others

Global NK Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (g)

Global NK Cells Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies NK Cells revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies NK Cells revenues share in global market, 2021 (%)
• Key companies NK Cells sales in global market, 2017-2022 (Estimated), (g)
• Key companies NK Cells sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Chipscreen Biosciences
• Affimed NV
• Altor BioScience
• Innate Pharma
• Takeda
• Sorrento Therapeutics
• NantKwest
• Bristol-Myers Squibb
• NKT
• Henry Ford Health Services
• Fortress Biotech